Integrated BioPharma, Inc. (INBP) Reports Q1 EPS of $0.00

Integrated BioPharma, Inc. (OTC: INBP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $13.1 million, versus $0 reported last year.

For earnings history and earnings-related data on Integrated BioPharma, Inc. (INBP) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Evolution Petroleum closes $16M Midland Basin royalty acquisition
• Largo restructures $82.2M in debt, extending maturity to 2030